These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8911655)
1. Prospects and advances in hormonal immunomodulatory therapy. Jorgensen C; Sany J Baillieres Clin Rheumatol; 1996 May; 10(2):379-92. PubMed ID: 8911655 [TBL] [Abstract][Full Text] [Related]
2. Management of early inflammatory arthritis. Intervention with immunomodulatory agents: new pharmacological developments. Veys EM; Mielants H; Verbruggen G; De Keyser F Baillieres Clin Rheumatol; 1992 Jun; 6(2):455-84. PubMed ID: 1525848 [No Abstract] [Full Text] [Related]
3. Pharmacological basis of immunotherapy in autoimmune diseases. Rouveix B; Blin O Clin Neuropharmacol; 1993 Apr; 16(2):104-12. PubMed ID: 8477406 [TBL] [Abstract][Full Text] [Related]
4. Can we use steroid hormones to immunomodulate rheumatic diseases? Rheumatoid arthritis as an example. Bijlsma JW Ann N Y Acad Sci; 1999 Jun; 876():366-76; discussion 376-7. PubMed ID: 10415630 [TBL] [Abstract][Full Text] [Related]
5. Immunopharmacology of the immunotherapy of cancer, infection, and autoimmunity. Hadden JW Fundam Clin Pharmacol; 1987; 1(4):283-96. PubMed ID: 3436614 [TBL] [Abstract][Full Text] [Related]
9. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice. Okudaira H; Terada E; Okudaira K Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985 [TBL] [Abstract][Full Text] [Related]
10. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases. Miller A; Hafler DA; Weiner HL FASEB J; 1991 Aug; 5(11):2560-6. PubMed ID: 1868980 [TBL] [Abstract][Full Text] [Related]
11. Hormonal Modulation of Dendritic Cells Differentiation, Maturation and Function: Implications for the Initiation and Progress of Systemic Autoimmunity. Mackern-Oberti JP; Jara EL; Riedel CA; Kalergis AM Arch Immunol Ther Exp (Warsz); 2017 Apr; 65(2):123-136. PubMed ID: 27585815 [TBL] [Abstract][Full Text] [Related]
12. Histamine-2 receptor antagonists as immunomodulators: new therapeutic views? Nielsen HJ Ann Med; 1996 Apr; 28(2):107-13. PubMed ID: 8732638 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D endocrine system and the immune response in rheumatic diseases. Cutolo M; Plebani M; Shoenfeld Y; Adorini L; Tincani A Vitam Horm; 2011; 86():327-51. PubMed ID: 21419278 [TBL] [Abstract][Full Text] [Related]
14. Immunopharmacology. Immunomodulation and immunotherapy. Hadden JW JAMA; 1987 Nov; 258(20):3005-10. PubMed ID: 3312684 [No Abstract] [Full Text] [Related]
15. [Immunotherapy in non-allergic diseases]. Español T Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379 [TBL] [Abstract][Full Text] [Related]
16. Antigen-Specific Tolerization and Targeted Delivery as Therapeutic Strategies for Autoimmune Diseases. Shakya AK; Nandakumar KS Trends Biotechnol; 2018 Jul; 36(7):686-699. PubMed ID: 29588069 [TBL] [Abstract][Full Text] [Related]
17. Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases. Perandini LA; de Sá-Pinto AL; Roschel H; Benatti FB; Lima FR; Bonfá E; Gualano B Autoimmun Rev; 2012 Dec; 12(2):218-24. PubMed ID: 22776785 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic measures in immunology]. Russo L Minerva Anestesiol; 1978 Oct; 44(10):737-79. PubMed ID: 375127 [No Abstract] [Full Text] [Related]